Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: A case report and review of the literature

22Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Primary breast lymphomas (PBLs) represent less than 1% of all breast malignancies. Intravascular large B-cell lymphoma (ILBCL) is a rare, aggressive form of extranodal lymphoma. Breast involvement has only been described in the literature once previously. ILBCL is characterized by the proliferation of tumour cells within the lumen of small vessels of involved organs, resulting in their eventual occlusion. Clinical features are often vague, diagnosis is difficult and delayed, and prognosis is usually poor. We report the first ever case of synchronous ILBCL and invasive ductal carcinoma (IDC) of the breast in a patient presenting with pyrexia of unknown origin and altered mental status who underwent modified radical mastectomy and subsequent chemotherapy, and review the literature regarding intravascular large B-cell lymphoma, PBLs and synchronous carcinomas and lymphomas of the breast. © 2014 Ho et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Ho, C. W. G., Mantoo, S., Lim, C. H., & Wong, C. Y. (2014). Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: A case report and review of the literature. World Journal of Surgical Oncology, 12(1). https://doi.org/10.1186/1477-7819-12-88

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free